Why This Framework Exists
According to global AI delivery standards, operational readiness—not algorithms—is the #1 predictor of AI success. Yet most pharmaceutical commercial teams invest heavily in AI technology while their operational foundations remain unprepared.
This diagnostic framework, based on PMI® AI standards and adapted for pharmaceutical commercial operations, helps you measure what actually matters: Can your operational foundation handle the weight of AI deployment?
How to Use This Diagnostic
Each pillar has: PMI Standard → Diagnostic Question → 3 Scoring Options (1, 3, or 5 points)
Score honestly based on your current operational reality, not aspirations. Most pharma teams score 9-13 points total.
The 5-Pillar Assessment
AI logic lives in individual expertise. Recommendations can't be explained to field teams.
Basic guardrails documented. You know what AI can't do, but not the business logic.
Every recommendation traceable. Reps understand what and why. Audit trail exists.
"We need AI because competitors have it." No clear business case or specific decision improved.
AI addresses concrete challenges: target reach, frequency, allocation. Integration unclear.
AI woven into commercial decisions. Territory planning, prioritization use AI as standard procedure.
Disconnected systems. Territory definitions in spreadsheets. IQVIA merged manually by one analyst.
Key datasets semi-consolidated. Some master data exists. Manual reconciliation still required.
Data flows automatically through validation to AI. No manual reconciliation. Field teams trust it.
Territory changes require stopping AI while ops manually reconfigure data and retrain models.
Standard changes have documented workarounds. Novel scenarios require custom intervention.
Business changes trigger automated model updates. Territory shifts propagate automatically.
Each business cycle requires emergency interventions. Models break. Field teams revert to manual.
AI performs reliably in controlled environments. Organizational changes require hands-on management.
Infrastructure handles business volatility. Launches, realignments, reorgs—models keep delivering.
Calculate Your Total Readiness Score
Add your scores across all 5 pillars
Interpreting Your Score
Reality: AI acceleration will expose weak foundations, not fix them.
Next Step: Fix the plumbing first. Invest in data governance, process documentation, automated reconciliation before deploying AI.
Reality: Strong intent exists, but last-mile execution limits scale.
Next Step: Focus on operational discipline. Document processes. Eliminate manual bottlenecks. The strategy is sound—execution readiness is the constraint.
Reality: Operationally ready to expand AI confidently.
Next Step: Expand AI use cases strategically. Leverage your operational advantage to compound competitive edge across commercial functions.
Reality: AI is embedded, trusted, and delivering sustained impact.
Next Step: Institutionalize capabilities. Document your playbook. Scale across enterprise. You're in the top tier—don't regress.
Most Pharma Teams Score 9–13 Points Because Strategy Outpaces Operational Readiness
When pharmaceutical commercial teams complete this assessment honestly, most score 9-13 points.
Strategy is compelling. Technology selection is sophisticated. Vision is clear. But execution breaks. And in AI deployment, a high score in strategy cannot compensate for a low score in operational readiness.
AI isn't "plug-and-play." It's "prepare-then-perform."
Ready for a deeper diagnostic?
MoatRx's comprehensive AI Readiness Assessment includes scoring across all 5 pillars, gap analysis, and a prioritized remediation roadmap.
